|
Saleheen D, Scott R, Javad S, Zhao W, Rodrigues A, Picataggi A, et al. |
Association of HDL cholesterol efflux capacity with incident coronary heart... |
Sunday, May 31, 2015 |
The lancet Diabetes & endocrinology |
|
Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale ... |
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in... |
Thursday, December 4, 2014 |
The lancet Diabetes & endocrinology |
|
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, ... |
Neuroinflammation in Alzheimer's disease |
Saturday, March 21, 2015 |
The Lancet Neurology |
|
Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, et al. |
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorour... |
Saturday, May 16, 2015 |
The Lancet Oncology |
|
Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. |
The expanding role of primary care in cancer control |
Sunday, October 4, 2015 |
The Lancet Oncology |
|
Lamb AD, Bratt O |
Towards ""next-generation"" prostate cancer screening |
Saturday, November 14, 2015 |
The Lancet Oncology |
|
Valle JW, Wasan H, Lopes A, Backen AC, Palmer DH, Morris K, et al. |
Cediranib or placebo in combination with cisplatin and gemcitabine chemothe... |
Friday, July 17, 2015 |
The Lancet Oncology |
|
Emma L O'Dowd, Richard W Lee , Ahsan R Akram, Emily C Bartlett, Stephe... |
Defining the road map to a UK national lung cancer screening programme |
|
The Lancet Oncology |
|
Tan CS, Gilligan D, Pacey S |
Treatment approaches for EGFR-inhibitor-resistant patients with non-small-c... |
Wednesday, September 16, 2015 |
The Lancet Oncology |
|
Basset-Seguin N, Hauschild A, Grob JJ, Kunstfeld R, Dreno B, Mortier L, et ... |
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-p... |
Wednesday, May 20, 2015 |
The Lancet Oncology |
